Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
/
DateNov 28 2023
SUNNYVALE, Calif., Nov. 28, 2023 /PRNewswire/ — Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the US Food and Drug Administration (FDA) has... Read More →